Inclusion of BIPOC individuals (Black, Indigenous, and people of color) in clinical research is critical for understanding how conditions develop in different populations. In a systematic review, researchers explored participant data from 12 North American multisite...
Amidst increasing popularity of semaglutide medications such as Wegovy and Ozempic, concerns have been raised that the glucagon-like peptide 1 receptor (GLP1R) agonist medications may increase suicidal thoughts. In a recent study, researchers analyzed electronic...
In a recent qualitative study, researchers explored the feasibility of artificial intelligence (AI) as a source of mental health support. Fourteen participants with mild-to-moderate anxiety or depression engaged in one immersive virtual reality therapy session with an...
In November, SAMHSA released results from the 2022 National Survey on Drug Use and Health (NSDUH), an annual, nationally representative survey on mental health, treatment rates, substance use, and more. Among U.S. adults, 23.1% experienced any mental illness (AMI) in...
Engagement and retention of participants in clinical mental illness research studies can be low. To better understand the perspectives of direct stakeholders, researchers surveyed individuals diagnosed with a schizophrenia spectrum condition (SSC) and caregivers of a...
Research suggests that experiencing substance-induced psychosis increases the risk of developing a schizophrenia spectrum disorder (SSD), but less is known about substance use without psychosis. In a study including 10 million people, Canadian researchers found that...
